Prognostic significance of ESR1 amplification and ESR1 Pvull, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients

Aleksandra Markiewicz , Marzena Wełnicka-Jaśkiewicz , Jarosław Skokowski , Janusz Jaśkiewicz , Jolanta Szade , Jacek Jassem , Anna Żaczek

Abstract

n/a
Author Aleksandra Markiewicz (IFB)
Aleksandra Markiewicz,,
- Intercollegiate Faculty of Biotechnology UG
, Marzena Wełnicka-Jaśkiewicz
Marzena Wełnicka-Jaśkiewicz,,
-
, Jarosław Skokowski
Jarosław Skokowski,,
-
, Janusz Jaśkiewicz
Janusz Jaśkiewicz,,
-
, Jolanta Szade
Jolanta Szade,,
-
, Jacek Jassem
Jacek Jassem,,
-
, Anna Żaczek (IFB / DMedB)
Anna Żaczek,,
- Department of Medical Biotechnology
Journal seriesPlos One, ISSN 1932-6203, (A 35 pkt)
Issue year2013
Vol8
No8
Pages1-10
DOIDOI:10.1371/journal.pone.0072219
URL http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072219
Languageen angielski
LicenseJournal (articles only); published final; Uznanie Autorstwa (CC-BY); with publication
Score (nominal)40
ScoreMinisterial score = 40.0, 21-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 40.0, 21-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2013 = 3.534 (2) - 2013=4.015 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back